A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Celcuity Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 11,045 shares of CELC stock, worth $138,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,045
Previous 51,556 78.58%
Holding current value
$138,393
Previous $844,000 80.57%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$13.98 - $19.15 $566,343 - $775,785
-40,511 Reduced 78.58%
11,045 $164,000
Q2 2024

Aug 09, 2024

SELL
$14.1 - $20.78 $328,530 - $484,174
-23,300 Reduced 31.13%
51,556 $844,000
Q1 2024

May 13, 2024

BUY
$13.74 - $21.6 $670,512 - $1.05 Million
48,800 Added 187.29%
74,856 $1.62 Million
Q4 2023

Feb 13, 2024

SELL
$8.7 - $15.02 $869 - $1,502
-100 Reduced 0.38%
26,056 $380,000
Q3 2023

Nov 14, 2023

SELL
$8.96 - $10.75 $43,904 - $52,675
-4,900 Reduced 15.78%
26,156 $239,000
Q2 2023

Aug 11, 2023

BUY
$9.39 - $12.18 $20,658 - $26,796
2,200 Added 7.62%
31,056 $341,000
Q1 2023

May 12, 2023

SELL
$9.4 - $12.82 $24,440 - $33,332
-2,600 Reduced 8.27%
28,856 $296,000
Q4 2022

Feb 13, 2023

SELL
$7.55 - $14.01 $189,505 - $351,651
-25,100 Reduced 44.38%
31,456 $441,000
Q3 2022

Nov 14, 2022

SELL
$8.0 - $10.64 $233,600 - $310,688
-29,200 Reduced 34.05%
56,556 $568,000
Q2 2022

Aug 12, 2022

BUY
$5.35 - $10.11 $60,989 - $115,254
11,400 Added 15.33%
85,756 $780,000
Q1 2022

May 13, 2022

BUY
$7.93 - $13.33 $347,334 - $583,854
43,800 Added 143.34%
74,356 $695,000
Q4 2021

Feb 11, 2022

BUY
$11.96 - $19.35 $60,996 - $98,685
5,100 Added 20.03%
30,556 $403,000
Q3 2021

Nov 12, 2021

SELL
$17.35 - $24.87 $152,680 - $218,856
-8,800 Reduced 25.69%
25,456 $458,000
Q2 2021

Aug 13, 2021

SELL
$14.25 - $30.93 $377,625 - $819,645
-26,500 Reduced 43.62%
34,256 $822,000
Q1 2021

May 13, 2021

BUY
$10.43 - $17.8 $83,909 - $143,201
8,045 Added 15.26%
60,756 $871,000
Q4 2020

Feb 10, 2021

SELL
$5.13 - $11.72 $1,246 - $2,847
-243 Reduced 0.46%
52,711 $483,000
Q3 2020

Nov 13, 2020

SELL
$5.1 - $7.07 $2,784 - $3,860
-546 Reduced 1.02%
52,954 $307,000
Q2 2020

Aug 13, 2020

SELL
$4.42 - $11.04 $35,183 - $87,878
-7,960 Reduced 12.95%
53,500 $371,000
Q1 2020

May 14, 2020

BUY
$5.79 - $11.78 $151,466 - $308,164
26,160 Added 74.11%
61,460 $399,000
Q4 2019

Feb 13, 2020

BUY
$9.47 - $16.71 $334,291 - $589,863
35,300 New
35,300 $376,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $187M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.